Dr. James Johnson

Share

Professor

Department of Cellular & Physiological Sciences

Prof. James Daniel Johnson, PhD is a Full Professor in the Department of Cellular and Physiological Sciences, in the Faculty of Medicine at the University of British Columbia. Prof. Johnson’s research focuses on the pathophysiology and signalling mechanisms underlying both type 1 and type 2 diabetes, obesity, longevity, heart disease, Alzheimer’s disease and pancreatic cancer, all at the molecular, cellular, and physiological systems levels. He has authored >185 peer-reviewed, high-impact publications, which can be found at Google Scholar along with citations metrics. Prof. Johnson is Editor-in-Chief of Islets and served on the Editorial Boards of Diabetes and of Endocrinology.

Website

LinkedIn

  • Islet Study Group 2023 (ISG 2023)

    June 19-21, 2023

  • https://www.youtube.com/watch?v=uNanCspBwhQ

    The University of British Columbia hosted the Islet Study Group meeting in June 2023 in the Life Sciences Institute. Profesor James Johnson played a crucial role in co-hosting along with the organizing committee of Islet Study Group members. Dr. Johnson and the committee welcomed over 250 delegates to campus. This meeting brought together international scientists studying islet biology to share their discoveries, enhance interactions, and encourage collaboration. The international islet research community discussed the exciting scientific developments within their field.

Publications

  • Skovsø S, Panzhinskiy E, Kolic J, Cen HH, Dionne DA, Dai XQ, Sharma RB, Elghazi L, Ellis CE, Faulkner K, Marcil SAM, Overby P, Noursadeghi N, Hutchinson D, Hu X, Li H, Modi H, Wildi JS, Botezelli JD, Noh HL, Suk S, Gablaski B, Bautista A, Kim R, Cras-Méneur C, Flibotte S, Sinha S, Luciani DS, Nislow C, Rideout EJ, Cytrynbaum EN, Kim JK, Bernal-Mizrachi E, Alonso LC, MacDonald PE, Johnson JD (2022) Beta-cell specific Insr deletion promotes insulin hypersecretion and improves glucose tolerance prior to global insulin resistance Nat Commun 13, 735 (2022).
    2022
  • Cen HH, Hussein B, Botezelli JD, Wang S, Zhang JA, Noursadeghi N, Jessen N, Rodrigues B, Timmons JA, Johnson JD (2022) Human and mouse muscle transcriptomic analyses identify insulin receptor mRNA downregulation in hyperinsulinemia‐associated insulin resistance FASEB
    2022
  • Zhang AMY, Magrill J, de Winter TJJ, Hu X, Skovsø S, Schaeffer DF, Kopp JL, Johnson JD (2019) Endogenous hyperinsulinemia contributes to pancreatic cancer development Cell metabolism
    2019